September - 2010
| Previous Past Months | Showing Journal 14 of 14 |
Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.Hauser CJ, Boffard K, Dutton R, Bernard GR et al J Trauma, 2010, 69(3):489-500 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
September |
Previous Comments
No Comments yet.
Comment
While recent studies show that Tranexamic Acid has some benefit in bleeding trauma patients, this randomised, placebo controlled trial has done little to help the cause of rFVIIa.